Back to BCRX
TCG Crossover Management, LLC → BCRX
TCG Crossover Management, LLC BCRX Position History
BioCryst Pharmaceuticals, Inc. • Healthcare
Quarters held
3
Latest value
$91.8M
Q3 2026
Peak value
$110.2M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $104.9M |
| Q2 2026 | $110.2M |
| Q3 2026 | $91.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $91.8M | 11.02M | — | — |
| Q2 2026 | $110.2M | 11.02M | — | — |
| Q1 2026 | $104.9M | 11.02M | — | — |
Other funds holding BCRX
$179.6M
$160.1M
$158.9M
$158.3M
$152.7M
$151.9M
$151.9M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC